Nutritive proteins and methods
Nutritive proteins are provided. In some embodiments the nutritive proteins comprise at least one of a level of a) a ratio of branch chain amino acid residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of branch chain amino acid residues to total amino acid residues present in whey protein; b) a ratio of leucine residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of leucine residues to total amino acid residues present in whey protein; and c) a ratio of essential amino acid residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of essential amino acid residues to total amino acid residues present in whey protein. Also provided are nucleic acids encoding the proteins, recombinant microorganisms that make the proteins, methods of making the proteins using recombinant microorganisms, compositions that comprise the proteins, and methods of using the proteins, among other things.
1. A method of maintaining or increasing at least one of muscle mass, muscle strength, or muscle functional performance in a subject, or reducing lean tissue loss in a subject, or achieving a desirable body mass index in a subject, the method comprising providing to the subject a sufficient amount of a nutritive protein comprising a polypeptide comprising a polypeptide sequence, wherein the polypeptide sequence comprises:
a. a ratio of branch chain amino acid residues to total amino acid residues of at least 24%;
b. a ratio of Leu residues to total amino acid residues of at least 11%; and
c. a ratio of essential amino acid residues to total amino acid residues of at least 49%, wherein the polypeptide sequence comprises:
a. at least 95% homology to at least 50 amino acids of naturally occurring nutritive protein,
and
b. less than 50% global homology to a known allergen wherein the isolated nutritive protein has an aqueous solubility at pH 7 of at least 12.5 g/L, and wherein the isolated nutritive protein is present in the composition in an amount of at least about 1 gram.
2. The method of claim 1 , wherein the polypeptide sequence comprises a calculated solvation score of −20 or less and a calculated aggregation score of 0.75or less.
3. The method of claim 1 , wherein the polypeptide sequence comprises an amino acid sequence selected from:
i. an amino acid sequence selected from the sequences shown in a SEQ ID list;
ii. a modified derivative of an amino acid sequence selected from the sequences shown in a SEQ ID list; and
iii. a mutein of an amino acid sequence selected from the sequences shown in a SEQ ID list;
wherein the SEQ ID list consists of SEQ ID NOs: 1-269, 275-284, 286, 295-313, 317, 318, 331-333, 335-341, 352, 361, 362, 367, 369-371, 381-388, 396-398, 404-411, 416, 419-421, 427, 431, 432, 434, 436, 440, 444, 446, 451, 454, 455, 457-460, 462-465, 467-473, 476, 477, 480, 481, 483, 485, 486, 488, 491, 494-497, 499, 500, 502, 503, 508, 510, 511, 513-515, 517-519, 521-526, 533, 534, 536-538, 542-544, 551, 552, 562, 563, 565, 566, 570, 571, 574-579, 581-584, 586-589, 591, 592, 596-608, 610, 613, 614, 616, 618-620, 627, 629, 632, 634, 640, 641, 643, 644, 646-648, 650, 653, 656-658, 663, 664, 671, 679, 686, 698, 701, 720-722, 727, 729, 731, 737, 738, 740, 744-747, 751, 755, 756, 759, 760, and 763.
4. The method of claim 1 , wherein the polypeptide sequence consists of an amino acid sequence selected from:
i. an amino acid sequence selected from the sequences shown in a SEQ ID list;
ii. a modified derivative of an amino acid sequence selected from the sequences shown in a SEQ ID list; and
iii. a mutein of an amino acid sequence selected from the sequences shown in a SEQ ID list;
wherein the SEQ ID list consists of SEQ ID NOs: 1-269, 275-284, 286, 295-313, 317, 318, 331-333, 335-341, 352, 361, 362, 367, 369-371, 381-388, 396-398, 404-411, 416, 419-421, 427, 431, 432, 434, 436, 440, 444, 446, 451, 454, 455, 457-460, 462-465, 467-473, 476, 477, 480, 481, 483, 485, 486, 488, 491, 494-497, 499, 500, 502, 503, 508, 510, 511, 513-515, 517-519, 521-526, 533, 534, 536-538, 542-544, 551, 552, 562, 563, 565, 566, 570, 571, 574-579, 581-584, 586-589, 591, 592, 596-608, 610, 613, 614, 616, 618-620, 627, 629, 632, 634, 640, 641, 643, 644, 646-648, 650, 653, 656-658, 663, 664, 671, 679, 686, 698, 701, 720-722, 727, 729, 731, 737, 738, 740, 744-747, 751, 755, 756, 759, 760, and 763.
5. The method of claim 1 , wherein the polypeptide sequence is at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 99.5% homologous to at least one amino acid sequence selected from the sequences shown in SEQ ID NO: 1-269, 275-284, 286, 295-313, 317, 318, 331-333, 335-341, 352, 361, 362, 367, 369-371, 381-388, 396-398, 404-411, 416, 419-421, 427, 431, 432, 434, 436, 440, 444, 446, 451, 454, 455, 457-460, 462-465, 467-473, 476, 477, 480, 481, 483, 485, 486, 488, 491, 494-497, 499, 500, 502, 503, 508, 510, 511, 513-515, 517-519, 521-526, 533, 534, 536-538, 542-544, 551, 552, 562, 563, 565, 566, 570, 571, 574-579,581-584, 586-589, 591, 592, 596-608, 610, 613, 614, 616, 618-620, 627, 629, 632, 634, 640, 641, 643, 644, 646-648, 650, 653, 656-658, 663, 664, 671, 679, 686, 698, 701, 720-722, 727, 729, 731, 737, 738, 740, 744-747, 751, 755, 756, 759, 760,and 763.
6. The method of claim 1 , wherein the isolated nutritive protein has a simulated gastric digestion half-life shorter than 60 minutes, and wherein the isolated nutritive protein is present in an amount of at least 2 g, 3 g, 4 g, 5 g, 6 g, 7 g, 8 g, 9 g, 10 g, 15 g, 20 g, 25 g, 30 g, 35 g, 40 g, 45 g, 50 g, 55 g, 60 g, 65 g, 70 g, 75 g, 80 g, 85 g, 90 g, 95 g, or 100 g.
7. The method of claim 1 , wherein the nutritive protein is formulated in a pharmaceutical composition comprising at least one component selected from a protein, a polypeptide, a peptide, a free amino acid, a carbohydrate, a lipid, a mineral or mineral source, a vitamin, a supplement, an organism, a pharmaceutical, and an excipient.
8. The method of claim 1 , wherein the subject is at least one of elderly, critically-medically ill, frail, obese, or suffering from protein-energy malnutrition, cachexia, sarcopenia, osteoporosis, chronic obstructive pulmonary disease, chronic heart failure, HIV, or other disease states.
9. The method of claim 1 , wherein the nutritive protein is consumed at a rate of from 0.1 g to 1 g a day, 1 g to 5 g a day, from 2 g to 10 g a day, from 5 g to 15 g a day, from 10 g to 20 g a day, from 15 g to 30 g a day, from 20 g to 40 g a day, from 25 g to 50 g a day, from 40 g to 80 g a day, from 50 g to 100 g a day, or more.
10. The method of claim 1 , wherein the nutritive protein comprises at least about 5% of the total protein intake by the subject over a dietary period, and/or the nutritive protein accounts for at least about 5% of the total calorie intake by the subject over a dietary period.
11. The method of claim 1 , wherein the nutritive protein is provided in a sufficient amount to induce in an obese subject a satiation response and/or a satiety response in the subject.
12. The method of claim 1 , wherein the nutritive protein exhibits no detectable aggregation at 95° C.
13. The method of claim 1 , wherein the polypeptide sequence does not comprise N-linked glycosylation or O-linked glycosylation.
14. The method of claim 1 , wherein the polypeptide sequence comprises at least one of each essential amino acid.
15. The method of claim 1 , wherein the polypeptide has a simulated gastric digestion half-life shorter than 2, 10, 30, or 60 minutes.
16. The method of claim 1 , wherein the polypeptide comprises a sequence selected from a sequence set forth in SEQ ID NOs: 751, 755, 756, 759, 760, and 763.